Introduction
In modern echocardiography, Ejection Fraction (EF) has traditionally been the most commonly used parameter to assess left ventricular systolic function. However, many patients may develop subclinical myocardial dysfunction even when EF appears normal. This is where Global Longitudinal Strain (GLS) becomes extremely valuable.
Strain imaging allows cardiologists to detect early myocardial damage before conventional parameters such as EF begin to decline. As a result, GLS has become an essential tool in the evaluation of patients with cardiomyopathy, chemotherapy exposure, and valvular heart disease.
---
What is Global Longitudinal Strain (GLS)?
Global Longitudinal Strain (GLS) is an echocardiographic parameter derived from speckle-tracking echocardiography that measures the percentage of myocardial deformation (shortening) in the longitudinal direction during systole.
In simple terms, GLS evaluates how well myocardial fibers shorten from the base to the apex during contraction.
Because myocardial fibers shorten during systole, GLS values are expressed as negative percentages.
Example:
A value of −20% indicates stronger contraction than −15%.
Thus, more negative values indicate better myocardial contractility.
---
Why GLS Is Important
EF can remain normal for a long time despite underlying myocardial injury. GLS detects subclinical ventricular dysfunction much earlier.
Key advantages of GLS include:
• Detects early myocardial damage before EF declines
• Provides quantitative assessment of myocardial deformation
• Helps in risk stratification and early therapeutic intervention
• Highly useful in cardio-oncology and cardiomyopathies
Because of these benefits, GLS is now recommended by ASE and EACVI guidelines in several clinical scenarios.
---
Normal GLS Values
Interpretation of GLS generally follows these commonly accepted ranges.
GLS Value Interpretation Clinical Meaning
≤ −20% Normal Good myocardial contraction
−16% to −20% Borderline / Watch Possible early dysfunction
> −16% Abnormal Significant systolic impairment
These thresholds may vary slightly depending on vendor software, imaging quality, and patient factors, but they provide a practical clinical framework.
---
How GLS is Measured
GLS is obtained using 2D speckle-tracking echocardiography from the following apical views:
• Apical 4-chamber
• Apical 2-chamber
• Apical 3-chamber (long axis)
The software tracks natural acoustic markers called speckles within the myocardium during the cardiac cycle. By analyzing the displacement of these speckles, the system calculates segmental and global strain values.
The final GLS value represents the average strain of all LV segments.
---
Clinical Applications of GLS
1. Cardio-Oncology (Chemotherapy Monitoring)
Certain chemotherapeutic drugs such as anthracyclines and trastuzumab can cause myocardial injury.
GLS is extremely useful because:
• It detects cardiotoxicity earlier than EF
• A relative reduction of >15% from baseline GLS suggests subclinical cardiotoxicity
Early detection allows clinicians to modify chemotherapy or start cardioprotective therapy before heart failure develops.
---
2. Heart Failure with Preserved EF (HFpEF)
Patients with HFpEF often have normal EF but impaired myocardial mechanics.
GLS helps reveal subclinical systolic dysfunction that EF cannot detect. Reduced GLS in these patients correlates with:
• Worse symptoms
• Higher hospitalization risk
• Poorer outcomes
---
3. Valvular Heart Disease
In conditions like:
• Aortic stenosis
• Mitral regurgitation
GLS can detect early LV dysfunction before EF declines, helping clinicians determine optimal timing for valve intervention.
---
4. Ischemic Heart Disease
Regional strain abnormalities may identify subtle myocardial ischemia or infarction, even when wall motion abnormalities are not obvious.
GLS also helps in prognostic risk assessment after myocardial infarction.
---
5. Cardiomyopathies
GLS provides valuable diagnostic clues in several cardiomyopathies.
Examples include:
• Hypertrophic cardiomyopathy
• Dilated cardiomyopathy
• Amyloidosis
In cardiac amyloidosis, GLS often shows the classic “apical sparing” pattern, which is highly suggestive of the disease.
---
GLS vs Ejection Fraction
Feature GLS EF
Detects early dysfunction Yes Often late
Sensitive to myocardial injury High Moderate
Quantitative deformation measure Yes No
Useful in cardio-oncology Excellent Limited
Detects subclinical disease Yes Often missed
Thus, GLS complements EF rather than replacing it.
---
Limitations of GLS
Despite its advantages, GLS has certain limitations:
• Vendor-dependent variability
• Requires good image quality
• Affected by loading conditions
• Requires experience and proper software
However, ongoing standardization by professional societies is improving its reliability.
---
Key Takeaways
• GLS measures myocardial deformation using speckle-tracking echocardiography.
• More negative GLS values indicate better myocardial contractility.
• GLS detects early ventricular dysfunction even when EF is normal.
• It is especially useful in chemotherapy monitoring, HFpEF, valvular disease, and cardiomyopathies.
• GLS is now increasingly incorporated into ASE and EACVI echocardiography guidelines.
---
Conclusion
Global Longitudinal Strain has transformed the evaluation of myocardial function by uncovering subclinical cardiac dysfunction that traditional EF measurements may miss. With growing evidence and guideline support, GLS is becoming an essential component of modern echocardiography.
In the era of precision cardiology, GLS allows clinicians to detect myocardial disease earlier, intervene sooner, and ultimately improve patient outcomes.
---
drmusmanjaved.com
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you